Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05502159Completed
Randomised, single-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Istanbul Medipol University. Primary endpoint: Quality of Recovery 15 at 24 hours. Started Aug 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05502159.